These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22054801)

  • 1. MDCT necrosis quantification in the assessment of hepatocellular carcinoma response to yttrium 90 radioembolization therapy: comparison of two-dimensional and volumetric techniques.
    Galizia MS; Töre HG; Chalian H; McCarthy R; Salem R; Yaghmai V
    Acad Radiol; 2012 Jan; 19(1):48-54. PubMed ID: 22054801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging of hepatocellular carcinoma after treatment with yttrium-90 microspheres.
    Keppke AL; Salem R; Reddy D; Huang J; Jin J; Larson AC; Miller FH
    AJR Am J Roentgenol; 2007 Mar; 188(3):768-75. PubMed ID: 17312067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiographically identified necrosis after 90Y microsphere brachytherapy: a new standard for oncologic response assessment?
    Welsh JS
    AJR Am J Roentgenol; 2007 Mar; 188(3):765-7. PubMed ID: 17312066
    [No Abstract]   [Full Text] [Related]  

  • 4. Early treatment response evaluation after yttrium-90 radioembolization of liver malignancy with CT perfusion.
    Reiner CS; Morsbach F; Sah BR; Puippe G; Schaefer N; Pfammatter T; Alkadhi H
    J Vasc Interv Radiol; 2014 May; 25(5):747-59. PubMed ID: 24630751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A simple method for estimating dose delivered to hepatocellular carcinoma after yttrium-90 glass-based radioembolization therapy: preliminary results of a proof of concept study.
    Kokabi N; Galt JR; Xing M; Camacho JC; Barron BJ; Schuster DM; Kim HS
    J Vasc Interv Radiol; 2014 Feb; 25(2):277-87. PubMed ID: 24461133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging of Hepatocellular Carcinoma Response After
    Semaan S; Makkar J; Lewis S; Chatterji M; Kim E; Taouli B
    AJR Am J Roentgenol; 2017 Nov; 209(5):W263-W276. PubMed ID: 29072955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response Assessment by Volumetric Iodine Uptake Measurement: Preliminary Experience in Patients with Intermediate-Advanced Hepatocellular Carcinoma Treated with Yttrium-90 Radioembolization.
    Bargellini I; Crocetti L; Turini FM; Lorenzoni G; Boni G; Traino AC; Caramella D; Cioni R
    Cardiovasc Intervent Radiol; 2018 Sep; 41(9):1373-1383. PubMed ID: 29654507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of positron emission tomography and bremsstrahlung imaging to detect particle distribution in patients undergoing yttrium-90 radioembolization for large hepatocellular carcinomas or associated portal vein thrombosis.
    Padia SA; Alessio A; Kwan SW; Lewis DH; Vaidya S; Minoshima S
    J Vasc Interv Radiol; 2013 Aug; 24(8):1147-53. PubMed ID: 23792126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment planning and volumetric response assessment for Yttrium-90 radioembolization: semiautomated determination of liver volume and volume of tumor necrosis in patients with hepatic malignancy.
    Monsky WL; Garza AS; Kim I; Loh S; Lin TC; Li CS; Fisher J; Sandhu P; Sidhar V; Chaudhari AJ; Lin F; Deutsch LS; Badawi RD
    Cardiovasc Intervent Radiol; 2011 Apr; 34(2):306-18. PubMed ID: 20683722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor growth kinetics versus RECIST to assess response to locoregional therapy in breast cancer liver metastases.
    Seyal AR; Parekh K; Velichko YS; Salem R; Yaghmai V
    Acad Radiol; 2014 Aug; 21(8):950-7. PubMed ID: 24833565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging Predictors of Elevated Lung Shunt Fraction in Patients Being Considered for Yttrium-90 Radioembolization.
    Olorunsola OG; Kohi MP; Behr SC; Kolli PK; Taylor AG; Tong RT; LaBerge JM; Kerlan RK; Fidelman N
    J Vasc Interv Radiol; 2015 Oct; 26(10):1472-8. PubMed ID: 26296737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiologic-pathologic correlation of hepatocellular carcinoma treated with internal radiation using yttrium-90 microspheres.
    Riaz A; Kulik L; Lewandowski RJ; Ryu RK; Giakoumis Spear G; Mulcahy MF; Abecassis M; Baker T; Gates V; Nayar R; Miller FH; Sato KT; Omary RA; Salem R
    Hepatology; 2009 Apr; 49(4):1185-93. PubMed ID: 19133645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agreement between competing imaging measures of response of hepatocellular carcinoma to yttrium-90 radioembolization.
    Duke E; Deng J; Ibrahim SM; Lewandowski RJ; Ryu RK; Sato KT; Miller FH; Kulik L; Mulcahy MF; Larson AC; Salem R; Omary RA
    J Vasc Interv Radiol; 2010 Apr; 21(4):515-21. PubMed ID: 20172741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microsphere localization and dose quantification using positron emission tomography/CT following hepatic intraarterial radioembolization with yttrium-90 in patients with advanced hepatocellular carcinoma.
    Lea WB; Tapp KN; Tann M; Hutchins GD; Fletcher JW; Johnson MS
    J Vasc Interv Radiol; 2014 Oct; 25(10):1595-603. PubMed ID: 25156647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SPECT/CT with 99mTc-MAA in radioembolization with 90Y microspheres in patients with hepatocellular cancer.
    Hamami ME; Poeppel TD; Müller S; Heusner T; Bockisch A; Hilgard P; Antoch G
    J Nucl Med; 2009 May; 50(5):688-92. PubMed ID: 19372479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histogram Analysis of CT Perfusion of Hepatocellular Carcinoma for Predicting Response to Transarterial Radioembolization: Value of Tumor Heterogeneity Assessment.
    Reiner CS; Gordic S; Puippe G; Morsbach F; Wurnig M; Schaefer N; Veit-Haibach P; Pfammatter T; Alkadhi H
    Cardiovasc Intervent Radiol; 2016 Mar; 39(3):400-8. PubMed ID: 26216725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival in patients with hepatocellular carcinoma treated with 90Y-microsphere radioembolization. Prediction by 18F-FDG PET.
    Sabet A; Ahmadzadehfar H; Bruhman J; Sabet A; Meyer C; Wasmuth JC; Pieper CC; Biersack HJ; Ezziddin S
    Nuklearmedizin; 2014; 53(2):39-45. PubMed ID: 24777354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Yttrium-90 radioembolization as a bridge to liver transplantation: a single-institution experience.
    Tohme S; Sukato D; Chen HW; Amesur N; Zajko AB; Humar A; Geller DA; Marsh JW; Tsung A
    J Vasc Interv Radiol; 2013 Nov; 24(11):1632-8. PubMed ID: 24160821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of hepatocellular carcinoma response to
    Gordic S; Wagner M; Zanato R; Hectors S; Besa C; Kihira S; Kim E; Taouli B
    Cancer Imaging; 2019 May; 19(1):29. PubMed ID: 31142363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal liver metastasis after 90Y radioembolization therapy: pilot study of change in MDCT attenuation as a surrogate marker for future FDG PET response.
    Tochetto SM; Töre HG; Chalian H; Yaghmai V
    AJR Am J Roentgenol; 2012 May; 198(5):1093-9. PubMed ID: 22528898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.